Drug class · Oncology & immunology
Kinase inhibitors
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Bosulifbosutinib | Bosutinib monohydrate 400 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-193 |
| Bosulifbosutinib | Bosutinib monohydrate 100 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0135 |
| Bosulifbosutinib | Bosutinib monohydrate 400 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0193 |
| Bosulifbosutinib | Bosutinib monohydrate 100 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-1014 |
| Bosulifbosutinib | Bosutinib monohydrate 500 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0136 |
| Bosulifbosutinib | Bosutinib monohydrate 50 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0504 |
| Brukinsazanubrutinib | Zanubrutinib 80 mg/1 | CapsuleOral | BeOne Medicines USA, Inc. | 72579-011 |
| Brukinsazanubrutinib | Zanubrutinib 160 mg/1 | Tablet, Film coatedOral | BeOne Medicines USA, Inc. | 72579-122 |
| Baricitinib | Baricitinib 4 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-6885 |
| Bosutinib | Bosutinib 100 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-311 |
| Bosutinib | Bosutinib 500 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-312 |
| Bosutinib | Bosutinib 100 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-311 |
| Bosutinib | Bosutinib 500 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-312 |
| Bosutinib | Bosutinib 400 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc. | 75907-405 |
| Cabometyxcabozantinib | Cabozantinib s-malate 60 mg/1 | TabletOral | Exelixis, Inc. | 42388-023 |
| Cabometyxcabozantinib | Cabozantinib s-malate 20 mg/1 | TabletOral | Exelixis, Inc. | 42388-024 |
| Cabometyxcabozantinib | Cabozantinib s-malate 40 mg/1 | TabletOral | Exelixis, Inc. | 42388-025 |
| Calquenceacalabrutinib | Acalabrutinib 100 mg/1 | Tablet, Film coatedOral | AstraZeneca Pharmaceuticals LP | 0310-3512 |
| Calquenceacalabrutinib | Acalabrutinib 100 mg/1 | Capsule, Gelatin coatedOral | AstraZeneca Pharmaceuticals LP | 0310-0512 |
| Calquenceacalabrutinib | Acalabrutinib 100 mg/1 | Tablet, Film coatedOral | AstraZeneca Pharmaceuticals LP | 0310-4513 |
| Caprelsavandetanib | Vandetanib 100 mg/1 | Tablet, Film coatedOral | Genzyme Corporation | 58468-7820 |
| Caprelsavandetanib | Vandetanib 300 mg/1 | Tablet, Film coatedOral | Genzyme Corporation | 58468-7840 |
| Cavhanzanilotinib | Nilotinib 60 mg/1 | Tablet, Orally disintegratingOral | Cycle Pharmaceuticals Ltd | 70709-191 |
| Cavhanzanilotinib | Nilotinib 80 mg/1 | Tablet, Orally disintegratingOral | Cycle Pharmaceuticals Ltd | 70709-192 |
| Cibinqoabrocitinib | Abrocitinib 50 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-236 |